Price
No data yet.
Social Signal Score
Analyst Ratings
16 analystsRevenue
$83.31M+41.83%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Robert A. Frist Jr.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Employees
- 1,150
- Beta
- 0.43
- Country
- US
- Piotroski score
- 7 / 9 (Strong)
- Altman Z-score
- 4.14
Financials
Revenue
$83.31M+41.8%Net Income
$5.37MEBITDA
$18.33M+221.1%Free Cash Flow
$9.98M+85.4%EPS (diluted)
$0.18Shares Outstanding (diluted)
29.66M-6.6%Operating Expenses
$35.45MCash & Debt
$115.16MReturn of Capital
$1.02MRevenue by Segment (annual)
$304.06MDividend per Share
$0.04Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $304.06M | $18.34M | $0.61 |
| 2024 | $291.65M | $20.01M | $0.66 |
| 2023 | $279.06M | $15.21M | $0.50 |
| 2022 | $266.83M | $12.09M | $0.39 |
| 2021 | $256.71M | $5.84M | $0.19 |
| 2020 | $244.83M | $14.09M | $0.44 |
| 2019 | $254.11M | $15.77M | $0.44 |
| 2018 | $231.62M | $32.22M | $1.00 |
| 2017 | $247.66M | $10.00M | $0.31 |
| 2016 | $225.97M | $3.75M | $0.12 |
| 2015 | $209.00M | $8.62M | $0.29 |
| 2014 | $170.69M | $10.39M | $0.38 |
| 2013 | $132.27M | $8.42M | $0.31 |
| 2012 | $103.73M | $7.64M | $0.29 |
Valuation
Project earnings forward and see what return today's price implies.
Seeded from HSTM's reported EPS growth of 5.9% a year over 13 years.
- EPS in 5 years
- $0.81
- Implied price
- $30.93
- Return from $26.29
- 3.3% a year
To earn 15.0% a year on these assumptions you'd need to buy at $15.38 — -41.5% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 26 | 32 | 38 | 44 | 50 |
|---|---|---|---|---|---|
| -4.1% | -13.3% | -9.6% | -6.5% | -3.7% | -1.2% |
| 0.9% | -8.8% | -4.9% | -1.6% | 1.4% | 4.0% |
| 5.9% | -4.2% | -0.2% | 3.3% | 6.4% | 9.1% |
| 10.9% | 0.3% | 4.5% | 8.2% | 11.4% | 14.3% |
| 15.9% | 4.8% | 9.2% | 13.1% | 16.4% | 19.4% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
54-66.25%Social Signal Score
Mentions (6)
- Newszacks.com·5d ago·Neutral
Down 16.9% in 4 Weeks, Here's Why HealthStream (HSTM) Looks Ripe for a Turnaround The heavy selling pressure might have exhausted for HealthStream (HSTM) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
View source ↗ - Newszacks.com·16d ago·Positive
HealthStream (HSTM) Upgraded to Buy: Here's What You Should Know HealthStream (HSTM) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
View source ↗ - Newsseekingalpha.com·19d ago·Positive
HealthStream, Inc. (HSTM) Q3 2026 Earnings Call Transcript HealthStream, Inc. ( HSTM ) Q3 2026 Earnings Call November 3, 2026 9:00 AM EST Company Participants Mollie Condra - Vice President of Investor Relations & Communications Robert Frist - Co-Founder, Chairman of the Board & CEO Scott Roberts - CFO and Senior VP of Accounting & Finance Conference Call Participants Matthew Hewitt - Craig-Hallum Capital Group LLC, Research Division Constantine Davides - Citizens JMP Securities, LLC, Research D…
View source ↗ - Newsmarketbeat.com·19d ago·Neutral
What HealthStream (HSTM) Said on Its Q3 Earnings Call HealthStream NASDAQ: HSTM raised its full-year outlook after reporting third-quarter revenue growth of 8.9%, while management highlighted investments in its technology platform, bundled workforce solutions and career-network offerings.
View source ↗ - Newszacks.com·20d ago·Positive
HealthStream (HSTM) Q3 Earnings and Revenues Surpass Estimates HealthStream (HSTM) came out with quarterly earnings of $0.18 per share, beating the Zacks Consensus Estimate of $0.15 per share. This compares to earnings of $0.2 per share a year ago.
View source ↗ - Newsbusinesswire.com·20d ago·Neutral
HealthStream Announces Third Quarter 2026 Results NASHVILLE, Tenn.--(BUSINESS WIRE)--HealthStream, Inc. (the "Company") (Nasdaq: HSTM), a leading healthcare technology platform company for clinical workforce solutions, today announced results for the third quarter ended September 30, 2026. Third Quarter 2026 Revenues of $83.3 million, up 8.9% from $76.5 million in the third quarter of 2025 Operating income of $6.6 million, down 13.0% from $7.6 million in the third quarter of 2025 Net income of $…
View source ↗
Earnings
Mon, Feb 22(in 3 months)
Consensus estimate $0.17 per share
Typical surprise +13.7% (median, so one quarter with a near-zero estimate can't distort it)
- Mon, Nov 2$0.18 vs $0.16beat
- Mon, Aug 3$0.23 vs $0.17beat
- Mon, May 4$0.20 vs $0.16beat
- Mon, Feb 23$0.09 vs $0.16miss
- Mon, Nov 3$0.20 vs $0.17beat
- Mon, Aug 4$0.18 vs $0.16beat
Estimates and results for HSTM via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by HSTM officers and directors.
- Bought
- —
- Sold
- $1.8m
0 trades
8 trades
- O'hara Kevin Psold
- Taylor Tate Deborahsold
- Roberts Scott Alexandersold
- Collier Michael Manningsold
- Collier Michael Manningsold
- Rebrovick Lindasold
- Frist Robert A Jrsold
- Rebrovick Lindasold
92 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
- Greg Gianfortehouse · MT00 · disclosed Jun 15, 2018 (8d later)Sell$50,001 - $100,000
Self-reported filings, amounts as brackets. Via Senate/House disclosures.
